Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
作者： Hendrik M. van Dullemen , Sander J.H. van Deventer , Daan W. Hommes , Hannie A. Bijl , Jaap Jansen
DOI: 10.1016/0016-5085(95)90277-5
关键词:
摘要: … use of anti-CD4 monoclonal antibodies to deplete the CD4 T-… the synthesis of high amounts of tumor necrosis factor (TNF) … , we used a chimeric monoclonal antibody that is known to …
gastrojournal.org
elsevier.com
core.ac.uk 
sci-hub.se 参考文章(15)
Emma J. Breese, Colin A. Michie, Stuart W. Nicholls, Simon H. Murch, Christopher B. Williams, Paola Domizio, John A. Walker-Smith, Thomas T. Macdonald, Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease Gastroenterology. ,vol. 106, pp. 1455- 1466 ,(1994) , 10.1016/0016-5085(94)90398-0
Steven L. Kunkel, Nicholas W. Lukacs, Robert M. Strieter, Kelly Warmington, Stephen W. Chensue, Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1. Journal of Immunology. ,vol. 152, pp. 5883- 5889 ,(1994)
David M. Knight, Han Trinh, Junming Le, Scott Siegel, David Shealy, Margaret McDonough, Bernard Scallon, Maria Arevalo Moore, Jan Vilcek, Peter Daddona, John Ghrayeb, Construction and initial characterization of a mouse-human chimeric anti-TNF antibody Molecular Immunology. ,vol. 30, pp. 1443- 1453 ,(1993) , 10.1016/0161-5890(93)90106-L
J Brynskov, N Tvede, Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin Gut. ,vol. 31, pp. 795- 799 ,(1990) , 10.1136/GUT.31.7.795
Mieke H. Godfried, Tom van der Poll, Jaap Jansen, Johannes A. Romijin, Jan K.M. Eeftinck Schattenkerk, Erik Endert, Sander J.H. van Deventer, Hans P. Sauerwein, Soluble receptors for tumour necrosis factor : a putative marker of disease progression in HIV infection AIDS. ,vol. 7, pp. 33- 36 ,(1993) , 10.1097/00002030-199301000-00005
Bert Derkx, Jan Taminiau, Sandra Radema, Arnold Stronkhorst, Cees Wortel, Guido Tytgat, Sander van Deventer, Tumour-necrosis-factor antibody treatment in Crohn's disease The Lancet. ,vol. 342, pp. 173- 174 ,(1993) , 10.1016/0140-6736(93)91375-V
T. T. MACDONALD, P. HUTCHINGS, M.-Y. CHOY, S. MURCH, A. COOKE, Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clinical and Experimental Immunology. ,vol. 81, pp. 301- 305 ,(2008) , 10.1111/J.1365-2249.1990.TB03334.X
M.J. Elliott, R.N. Maini, M. Feldmann, A. Long-Fox, P. Charles, J.A. Bijl, J.N. Woody, Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis The Lancet. ,vol. 344, pp. 1125- 1127 ,(1994) , 10.1016/S0140-6736(94)90632-7
C.P. Braegger, S. Nicholls, S.H. Murch, T.T. MacDonald, S. Stephens, Tumour necrosis factor alpha in stool as a marker of intestinal inflammation The Lancet. ,vol. 339, pp. 89- 91 ,(1992) , 10.1016/0140-6736(92)90999-J
Michael J. Elliott, Ravinder N. Maini, Marc Feldmann, Alice Long-Fox, Peter Charles, Peter Katsikis, Fionula M. Brennan, Jean Walker, Hanny Bijl, John Ghrayeb, James N. Woody, Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha Arthritis & Rheumatism. ,vol. 36, pp. 1681- 1690 ,(1993) , 10.1002/ART.1780361206